INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

BMRNBIOMARIN PHARMACEUTICAL INC

CIK 0001048477

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score17
Connections3with evidence

BMRN · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
RV
Ramchandani Rashmi VirendraVP, Chief Accounting Officer
BMRNBIOMARIN PHARMACEUTICAL INC
Grant or award
A—
18.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Lobbied forevidence
    BGR GOVERNMENT AFFAIRSLDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • ← Insider ofevidence
    Ramchandani Rashmi VirendraVP, Chief Accounting Officer · Jan 22, 2026
17
RV
Ramchandani Rashmi VirendraVP, Chief Accounting Officer
BMRNBIOMARIN PHARMACEUTICAL INC
Grant or award
A
—
7,070 sh
Jan 20, 2026
Jan 22, 2026
traded Jan 20, 2026
+2d
SEC FORM 4

Evidence

9
RV
Ramchandani Rashmi VirendraVP, Chief Accounting Officer
BMRNBIOMARIN PHARMACEUTICAL INC
Grant or award
A—
18.2K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

Lobbying

$1.55M reported · de-duplicated
2026 Q2 $1.02M in-house2026 Q1 $530K in-house
  • In-house report$340K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, TAR, MED
  • In-house report$340K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, TAR, MED
  • In-house report$530K2026 Q1 · posted Aug 26, 2026 · TAR, Health issues, Medicare/Medicaid
  • In-house report$340K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, TAR, MED
  • BGR GOVERNMENT AFFAIRS$50K2026 Q2 · posted Aug 26, 2026 · Health issues
  • BGR GOVERNMENT AFFAIRS$50K2026 Q1 · posted Aug 26, 2026 · Health issues

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.